Hardy W. Chan
Presidente presso ScinoPharm (Kunshan) Biochemical Technology Co., Ltd.
Posizioni attive di Hardy W. Chan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| National Cheng Kung University | Corporate Officer/Principal | - | - |
| ScinoPharm (Kunshan) Biochemical Technology Co., Ltd. | Presidente | 09/11/2010 | - |
Storia della carriera di Hardy W. Chan
Precedenti posizioni note di Hardy W. Chan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Tanvex BioPharma USA, Inc. | Amministratore Delegato | - | - |
| Syntex Corp. | Corporate Officer/Principal | - | - |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Direttore/Membro del Consiglio | 12/08/2010 | - |
| SCINOPHARM TAIWAN, LTD. | Fondatore | 09/11/2010 | - |
Formazione di Hardy W. Chan
| University of Wisconsin | Doctorate Degree |
Statistiche
Distribuzione geografica
| Taiwan | 4 |
| Stati Uniti | 4 |
| Cina | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCINOPHARM TAIWAN, LTD. | Health Technology |
| Aziende private | 4 |
|---|---|
| Syntex Corp. | Health Technology |
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
| ScinoPharm (Kunshan) Biochemical Technology Co., Ltd. | |
| Tanvex BioPharma USA, Inc. |
- Borsa valori
- Insiders
- Hardy W. Chan
- Esperienza
